Skip to Main Content

Paper Details

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response.
NAR Cancer
12
2022
LAR, LAR TNBC, LAR TNBC subtype, LAR TNBC tumors, LAR subtype, Luminal, Luminal androgen receptor breast cancer, Luminal androgen receptor breast cancer subtype, TILs, TNBC, TNBC subtype, TNBC subtypes, Triple-negative breast cancer, androgen, androgen receptor, breast cancer, cycling T-cells, luminal androgen receptor, myofibroblast-like cancer-associated cells, non-, patients, plasma cells, tumor, tumor infiltrating lymphocytes
Author NameAffiliation
Vera J SumanMayo Clinic
Lisa A CareyUniversity of North Carolina at Chapel Hill School of Medicine
James N IngleMayo Clinic
Minetta C LiuMayo Clinic
Eric W KleeMayo Clinic
Richard M WeinshilboumMayo Clinic
Judy C BougheyMayo Clinic
Liewei WangMayo Clinic
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Matthew P GoetzMayo Clinic
  • 1 - 11

Datasets

Release 1.2